Showing results (171-180 of 696) with videos related to
Sort By:
Pageof 70
Diabetes Research and Clinical Practice|June 21, 2016
Retinopathy is associated with impaired myocardial function assessed by advanced echocardiography in type 1 diabetes patients - The Thousand & 1 StudyNina Nouhravesh, Henrik U Andersen, Jan S Jensen, et al.Therapeutic Advances in Endocrinology and Metabolism|July 25, 2022
The potential of GLP-1 receptor agonists in type 2 diabetes and chronic kidney disease: from randomised trials to clinical practiceBernt Johan von Scholten, Frederik Flindt Kreiner, Søren Rasmussen, et al.Clinical Epidemiology|November 16, 2016
The Danish Adult Diabetes RegistryMarit Eika Jørgensen, Jette K Kristensen, Gitte Reventlov Husted, et al.Clinical Medicine Insights. Endocrinology and Diabetes|February 25, 2025
Long Term Outcomes After Flexor Tendon Tenotomy of the Diabetic FootJonas Askø Andersen, Anne Rasmussen, Marie Frimodt-Møller, et al.BMJ Open|June 9, 2017
Protocol for a randomised controlled trial of the effect of dapagliflozin, metformin and exercise on glycaemic variability, body composition and cardiovascular risk in prediabetes (the PRE-D Trial)Kristine Færch, Hanan Amadid, Lea Bruhn Nielsen, et al.Pharmaceuticals (Basel, Switzerland)|September 28, 2023
Prognosis and Personalized In Silico Prediction of Treatment Efficacy in Cardiovascular and Chronic Kidney Disease: A Proof-of-Concept StudyMayra Alejandra Jaimes Campos, Iván Andújar, Felix Keller, et al.Diabetes Care|July 8, 2010
Vitamin D levels and mortality in type 2 diabetesChristel Joergensen, Mari-Anne Gall, Anne Schmedes, et al.Diabetes Care|February 27, 2010
Urinary liver-type fatty acid-binding protein predicts progression to nephropathy in type 1 diabetic patientsStine Elkjaer Nielsen, Takeshi Sugaya, Peter Hovind, et al.Kidney International|October 2, 2004
Progression of nephropathy in type 2 diabetic patientsKasper Rossing, Per K Christensen, Peter Hovind, et al.Diabetes, Obesity & Metabolism|September 29, 2020
Relationship between peripheral neuropathy, diastolic function and adverse cardiovascular outcome in individuals with type 1 diabetes mellitus without known cardiovascular disease: Results from the Thousand & 1 StudyGorm Mørk Hansen, Peter Godsk Jørgensen, Henrik Ullits Andersen, et al.Pageof 70